William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business
Tweet Send to a Friend
(Updated - August 19, 2026 8:11 AM EDT)
William Blair analyst Myles Minter upgraded Moderna (NASDAQ: MRNA) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
William Blair analyst Myles Minter upgraded Moderna (NASDAQ: MRNA) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
